Your browser doesn't support javascript.
Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
Cherubini, Fabio; Cristiano, Antonio; Valentini, Alessandra; Bernardini, Sergio; Nuccetelli, Marzia.
  • Cherubini F; Department of Experimental Medicine, University of Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Cristiano A; Department of Experimental Medicine, University of Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Valentini A; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Bernardini S; Department of Experimental Medicine, University of Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Nuccetelli M; Tor Vergata University Hospital, Rome, Italy.
Inflamm Res ; 70(6): 687-694, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1217416
ABSTRACT
OBJECTIVE AND

DESIGN:

Fecal calprotectin (CLP) is widely known for its detection in stools of patients with inflammatory bowel diseases (IBDs), to investigate the intestinal inflammatory status. Current research is promoting the circulating protein role as a systemic inflammatory marker. However, most studies report serum calprotectin analysis although plasma assay prevents its massive release by granulocytes. In this perspective, the ongoing SARS-CoV-2 pandemic deserves deployment of convenient and easy-to-dose markers that could reliably address the state of infection.

METHODS:

We analyzed serum circulating calprotectin (cCLP) levels in hospitalized COVID-19 patients and plasma cCLP levels from patients with suspected SARS-CoV-2 infection, then assessed negative or positive on molecular tests.

RESULTS:

Our results confirm a significant circulating calprotectin increase in infected subjects respect to controls, in serum and plasma. Moreover, plasma calprotectin has higher levels in suspected patients with positive SARS-CoV-2-RT-PCR, compared to suspected patients with negative SARS-CoV-2-RT-PCR. Furthermore, ROC curves results showed the circulating plasma calprotectin discriminatory ability to differentiate infected SARS-CoV-2 patients at a cutoff value greater than 131.3 ng/ml.

CONCLUSIONS:

Our data propose circulating calprotectin as a new, quantitative and predictive marker, which in addition to being an interesting generic inflammatory marker may provide important indications in SARS-CoV-2 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Inflamm Res Journal subject: Allergy and Immunology / Pathology Year: 2021 Document Type: Article Affiliation country: S00011-021-01465-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Inflamm Res Journal subject: Allergy and Immunology / Pathology Year: 2021 Document Type: Article Affiliation country: S00011-021-01465-y